Exogenous levodopa is not toxic to elderly subjects with non-parkinsonian movement disorders: Further clinical evidence

J. Hagenah, C. Klein, M. Sieberer, P. Vieregge*

*Corresponding author for this work

Abstract

We report three women between 80 and 87 years of age who had longstanding essential tremor. Due to an erroneous diagnosis of Parkinsonism they had received levodopa preparations for 13, 16 and 25 years, respectively, with cumulative levodopa equivalent doses of 18.0, 9.0, and 4.1 kg. The patients showed neither dyskinesias nor signs of Parkinsonism. These observations do not support a detrimental role of chronic levodopa exposure in elderly individuals with essential tremor.

Original languageEnglish
JournalJournal of Neural Transmission
Volume106
Issue number3-4
Pages (from-to)301-307
Number of pages7
ISSN0300-9564
DOIs
Publication statusPublished - 06.05.1999

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities

Fingerprint

Dive into the research topics of 'Exogenous levodopa is not toxic to elderly subjects with non-parkinsonian movement disorders: Further clinical evidence'. Together they form a unique fingerprint.

Cite this